Story
BHP Halts Operations at World's Largest Copper Mine After Worker Fatality

Summary
BHP has suspended all activities at its Escondida mine in Chile, the world's largest copper producer, following a fatal accident involving a worker. The timeline for a restart is uncertain pending a safety inspection.
BHP has suspended all operations at its Escondida mine in Chile, the world's largest copper producer, following a fatal accident at the site on Wednesday. The indefinite halt could impact global copper supply, as the mine was projected to produce up to 1.28 million metric tons of the metal this year.
Details of the Suspension
In a statement, BHP confirmed a worker was killed while performing maintenance work. As a result, the company said, "All operational activities at the mine have been suspended." BHP did not provide a timeline for when operations might resume.
The union representing workers at the site had previously told Reuters that the accident involved a front-end loader, a piece of heavy equipment common in the industry.
Potential Market Impact
The Escondida mine is a critical component of the global copper market. An extended shutdown could tighten the supply of the industrial metal, which is a key material for construction, manufacturing, and the green energy transition.
AdUnder typical Chilean regulatory procedures, mining activities may only restart after a fatal incident once government inspectors have verified that conditions are safe. This process adds uncertainty to the duration of the production halt.
Mine Ownership and Context
The Escondida mine is located in Chile’s Atacama Desert. While BHP is the operator, other major mining firms hold significant stakes in the asset:
- Rio Tinto holds a 30% interest.
- Japan-based JECO Corp holds a 12.5% stake.
Read next
More on Stocks
Peloton Reportedly Explores $800 Million Debut Bond Sale
Peloton Interactive is considering its first-ever bond offering to raise $800 million, according to a Bloomberg report citing people familiar with the matter. The news sent the company's shares down over 4% in Wednesday trading.

1789 Capital Seeks $3 Billion for Second Growth Fund, Bloomberg Reports
The investment firm, where Donald Trump Jr. is a partner, has reportedly secured $2 billion toward its target for a new fund focused on larger investments in sectors like AI and defense.

Arcturus Stock Gains on Positive Drug Trial Data and New mRNA Platform
Arcturus Therapeutics shares rose after the company released encouraging interim Phase 2 data for its OTC deficiency treatment and unveiled a next-generation mRNA delivery platform with significantly higher potency.

Gossamer Bio Shares Climb After Filing First-Ever FDA Drug Application for Seralutinib
The clinical-stage biopharmaceutical company has submitted a New Drug Application for its pulmonary arterial hypertension treatment, seralutinib, prompting a rise in its stock during after-hours trading.